The Ottawa Hospital (TOH) is set to implement the extubation advisor (EA), an AI clinical support tool developed by Canadian company Therapeutic Monitoring Systems (TMS).

This tool is designed to assist clinicians in making informed extubation decisions within the hospital's intensive care units (ICUs).

Implemented through nonprofit OBIO’s Life Sciences Critical Technology and Commercialization (LSCTC) Centre for Excellence, the tool aims to enhance clinical judgement by providing patient-specific, data-driven insights. It has now entered a phase of real-world evaluation at the hospital.

The EA followed successful evaluations at TOH and Unity Health under OBIO’s Early Adopter Health Network programme, supported by the Canadian Government via FedDev Ontario, with LSCTC backed by the Ontario government.

TMS CEO and TOH thoracic surgery chief Dr Andrew Seely said: “This tool represents more than a decade of research into how patient data can guide better care.

“Extubation decisions are some of the most difficult ones we make in the ICU, and the EA gives clinicians access to real-time, evidence-based predictions to help guide those moments. We’re grateful to OBIO for helping translate research into practice in a way that has the potential to benefit patients across Canada and internationally.”

The technology complements existing practice by offering personalised insights that are expected to help reduce stays in ICUs while minimising ventilation-related complications.

OBIO president and CEO Dr Maura Campbell said: “This partnership with The Ottawa Hospital and Therapeutic Monitoring Systems is a powerful demonstration of how made-in-Ontario AI-powered tools can be successfully integrated into critical care to improve patient outcomes.”

Health Canada and the European Union granted clearance to the EA.